Abstract:Ubiquitin and the ∼20 human ubiquitin-like proteins regulate numerous aspects of cell biology via interlinked mechanisms that have not been fully elucidated. Sha et al. now explore the interplay between ubiquitylation and SUMOylation, finding that inhibition of ubiquitylation enhances SUMOylation of hundreds of newly synthesized proteins and that the resultant pools are stored in phase-separated protein condensates called PML nuclear bodies. These unexpected outcomes identify a new role for SUMOylation and raise new questions about cell behavior under normal and stress conditions. Ubiquitin and the ∼20 human ubiquitin-like proteins regulate numerous aspects of cell biology via interlinked mechanisms that have not been fully elucidated. Sha et al. now explore the interplay between ubiquitylation and SUMOylation, finding that inhibition of ubiquitylation enhances SUMOylation of hundreds of newly synthesized proteins and that the resultant pools are stored in phase-separated protein condensates called PML nuclear bodies. These unexpected outcomes identify a new role for SUMOylation and raise new questions about cell behavior under normal and stress conditions. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodiesJournal of Biological ChemistryVol. 294Issue 42PreviewProtein ubiquitination and SUMOylation are required for the maintenance of cellular protein homeostasis, and both increase in proteotoxic conditions (e.g. heat shock or proteasome inhibition). However, we found that when ubiquitination was blocked in several human cell lines by inhibiting the ubiquitin-activating enzyme with TAK243, there was an unexpected, large accumulation of proteins modified by SUMO2/3 chains or SUMO1, but not by several other ubiquitin-like proteins. This buildup of SUMOylated proteins was evident within 3–4 h. Full-Text PDF Open Access

Ube1dc1, an Ubiquitin-Activating Enzyme, Activates Two Different Ubiquitin-Like Proteins

Isolation and Characterization of Ubiquitin-activating Enzyme E1-domain Containing 1, UBE1DC1

Expression, Purification and Characterization of Human Ubiquitin-Activating Enzyme, UBE1

UBE2G1 governs the destruction of cereblon neomorphic substrates.

UBE2A and UBE2B are recruited by an atypical E3 ligase module in UBR4

UBE2G1 Governs the Destruction of Cereblon Neomorphic Substrates

UBE2M is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation That Promotes Targeted Degradation of UBE2F.

Structural Visualization of HECT-E3 Ufd4 accepting and transferring Ubiquitin to Form K29/K48-branched Polyubiquitination on N-degron

A structurally unique E2-binding domain activates ubiquitination by the ERAD E2, Ubc7p, through multiple mechanisms.

Legionella effector MavC targets the Ube2N~Ub conjugate for noncanonical ubiquitination

Global analysis of protein and small-molecule substrates of ubiquitin-like proteins (UBLs)

Structure-guided engineering enables E3 ligase-free and versatile protein ubiquitination via UBE2E1

A Modular Turn‐On Strategy to Profile E2‐Specific Ubiquitination Events in Living Cells

The E3 Ligase APC/C-Cdh1 Regulates MEF2A-dependent Transcription by Targeting SUMO-specific Protease 2 for Ubiquitination and Degradation.

Interplay Between Ubiquitylation and SUMOylation: Empowered by Phase Separation

Mono-ubiquitination Drives Nuclear Export of the Human DCN1-like Protein Hdcnl1.

UBE4A catalyzes NRF1 ubiquitination and facilitates DDI2-mediated NRF1 cleavage

Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2

The Potential Role of Ubiquitin C-Terminal Hydrolases in Oncogenesis

Structural Insights Into the Initiation and Elongation of Ubiquitination by Ubr1

Physiologically relevant and portable tandem ubiquitin-binding domain stabilizes polyubiquitylated proteins